Acetylcysteine Oral and Inhalation Solution Shortage

• • Acetylcysteine solution, Pfizer, 100 mg/mL, 30 mL vial, 3 count, NDC 00409-3307-03
  • Acetylcysteine solution, Pfizer, 200 mg/mL, 30 mL vial, 3 count, NDC 00409-3308-03

• • American Regent has acetylcysteine oral and inhalation solution available. They are not currently marketing the 200 mg/mL 30 mL vials.
  • Arbor discontinued Cetylev effervescent tablets in April 2019.
  • Fresenius Kabi did not provide a reason for the shortage.
  • Pfizer has acetylcysteine oral and inhalation solution on shortage due to manufacturing delays.

• • Acetylcysteine solution, American Regent, 100 mg/mL, 4 mL vial, 25 count, NDC 00517-7504-25
  • Acetylcysteine solution, American Regent, 200 mg/mL, 4 mL vial, 3 count, NDC 00517-7604-25
  • Acetylcysteine solution, Fresenius Kabi, 100 mg/mL, 10 mL vial, 3 count, NDC 63323-0693-10
  • Acetylcysteine solution, Fresenius Kabi, 100 mg/mL, 30 mL vial, 3 count, NDC 63323-0691-30
  • Acetylcysteine solution, Fresenius Kabi, 100 mg/mL, 4 mL vial, 25 count, NDC 63323-0695-04
  • Acetylcysteine solution, Fresenius Kabi, 200 mg/mL, 10 mL vial, 3 count, NDC 63323-0692-10
  • Acetylcysteine solution, Fresenius Kabi, 200 mg/mL, 30 mL vial, 3 count, NDC 63323-0690-30
  • Acetylcysteine solution, Fresenius Kabi, 200 mg/mL, 4 mL vial, 3 count, NDC 63323-0694-04

Estimated Resupply Dates

• • Pfizer has acetylcysteine 100 mg/mL 30 mL vials and 200 mg/mL 30 mL vials on back order and the company estimates a release date of July 2024 for the 100 mg/mL 30 mL vials and June 2024 for the 200 mg/mL 30 mL vials.